Free Trial
NASDAQ:GRAL

Grail (GRAL) Stock Price, News & Analysis

Grail logo
$27.00 +0.50 (+1.89%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$27.86 +0.86 (+3.17%)
As of 04/17/2025 05:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Grail Stock (NASDAQ:GRAL)

Key Stats

Today's Range
$25.56
$27.40
50-Day Range
$21.39
$55.02
52-Week Range
$12.33
$63.99
Volume
642,745 shs
Average Volume
1.22 million shs
Market Capitalization
$953.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.00
Consensus Rating
Hold

Company Overview

GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

Grail Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
14th Percentile Overall Score

GRAL MarketRank™: 

Grail scored higher than 14% of companies evaluated by MarketBeat, and ranked 876th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Grail has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Grail has only been the subject of 1 research reports in the past 90 days.

  • Read more about Grail's stock forecast and price target.
  • Percentage of Shares Shorted

    17.48% of the float of Grail has been sold short.
  • Short Interest Ratio / Days to Cover

    Grail has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Grail has recently increased by 38.62%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Grail does not currently pay a dividend.

  • Dividend Growth

    Grail does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    17.48% of the float of Grail has been sold short.
  • Short Interest Ratio / Days to Cover

    Grail has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Grail has recently increased by 38.62%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Grail has a news sentiment score of 1.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for Grail this week, compared to 6 articles on an average week.
  • Search Interest

    Only 11 people have searched for GRAL on MarketBeat in the last 30 days. This is a decrease of -21% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added Grail to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Grail insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $360,436.00 in company stock.

  • Read more about Grail's insider trading history.
Receive GRAL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Grail and its competitors with MarketBeat's FREE daily newsletter.

GRAL Stock News Headlines

CareDx (NASDAQ:CDNA) versus Grail (NASDAQ:GRAL) Head-To-Head Analysis
GRAIL, Inc. (GRAL): A Bull Case Theory
The real reason gold is soaring (and likely to continue)
Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driving a hidden gold market boom. Garrett Goggin, a renowned precious metals expert with 20+ years of experience, reveals 5 explosive investment opportunities set to explode in this new era. Backed by triple-digit returns in 2024, Garrett’s insights show you how to position yourself for wealth in 2025. Don’t wait—these opportunities can disappear fast!
Finalist: Marissa Song
Grail price target raised to $20 from $16 at Morgan Stanley
See More Headlines

GRAL Stock Analysis - Frequently Asked Questions

Grail's stock was trading at $17.85 on January 1st, 2025. Since then, GRAL stock has increased by 51.3% and is now trading at $27.00.
View the best growth stocks for 2025 here
.

Grail, Inc. (NASDAQ:GRAL) released its quarterly earnings results on Thursday, February, 20th. The company reported ($1.86) EPS for the quarter, beating the consensus estimate of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million.
Read the conference call transcript
.

Top institutional investors of Grail include 180 Wealth Advisors LLC (0.30%), Alpha Wealth Funds LLC (0.12%), Wesbanco Bank Inc. (0.09%) and Wealth Enhancement Advisory Services LLC (0.08%). Insiders that own company stock include Chun R Ding, Robert P Ragusa, Joshua J Ofman and Aaron Freidin.
View institutional ownership trends
.

Shares of GRAL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Grail investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Visa (V).

Company Calendar

Last Earnings
2/20/2025
Today
4/20/2025
Next Earnings (Estimated)
5/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NASDAQ:GRAL
Previous Symbol
NASDAQ:GRAL
Web
N/A
Fax
N/A
Employees
1,360
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.00
High Stock Price Target
$20.00
Low Stock Price Target
$20.00
Potential Upside/Downside
-25.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$125.60 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$953.02 million
Optionable
Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:GRAL) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners